Susanne J Maurer1, Ulrike M M Bauer2, Helmut Baumgartner3, Anselm Uebing4, Claudia Walther5, Oktay Tutarel6,7. 1. Department of Electrophysiology, German Heart Centre Munich, TUM School of Medicine-Technical University of Munich, 80636 Munich, Germany. 2. National Register for Congenital Heart Defects, Competence Network for Congenital Heart Defects, 13353 Berlin, Germany. 3. Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert-Schweitzer Campus 1, 48149 Muenster, Germany. 4. Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany. 5. Department of Cardiology, University of Frankfurt, 60590 Frankfurt am Main, Germany. 6. Department of Congenital Heart Disease and Paediatric Cardiology, German Heart Centre Munich, TUM School of Medicine-Technical University of Munich, 80636 Munich, Germany. 7. DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80992 Munich, Germany.
Abstract
BACKGROUND: As adults with congenital heart disease (ACHD) are getting older, acquired comorbidities play an important role in morbidity and mortality. Data regarding their prevalence in ACHD that are representative on a population level are not available. METHODS: The German National Register for Congenital Heart Defects was screened for ACHD. Underlying congenital heart disease (CHD), patient demographics, previous interventional/surgical interventions, and comorbidities were retrieved. Patients <40 years of age were compared to those ≥40 years. RESULTS: A total of 4673 patients (mean age 33.6 ± 10.7 years, female 47.7%) was included. At least one comorbidity was present in 2882 patients (61.7%) altogether, and in 56.8% of patients below vs. 77.7% of patients over 40 years of age (p < 0.001). Number of comorbidities was higher in patients ≥40 years (2.1 ± 2.1) than in patients <40 years (1.2 ± 1.5, p < 0.001). On multivariable regression analysis, age and CHD complexity were significantly associated with the presence and number of comorbidities. CONCLUSIONS: At least one acquired comorbidity is present in approximately two-thirds of ACHD. Age and complexity of the CHD are significantly associated with the presence of comorbidities. These findings highlight the importance of addressing comorbidities in ACHD care to achieve optimal long-term outcomes.
BACKGROUND: As adults with congenital heart disease (ACHD) are getting older, acquired comorbidities play an important role in morbidity and mortality. Data regarding their prevalence in ACHD that are representative on a population level are not available. METHODS: The German National Register for Congenital Heart Defects was screened for ACHD. Underlying congenital heart disease (CHD), patient demographics, previous interventional/surgical interventions, and comorbidities were retrieved. Patients <40 years of age were compared to those ≥40 years. RESULTS: A total of 4673 patients (mean age 33.6 ± 10.7 years, female 47.7%) was included. At least one comorbidity was present in 2882 patients (61.7%) altogether, and in 56.8% of patients below vs. 77.7% of patients over 40 years of age (p < 0.001). Number of comorbidities was higher in patients ≥40 years (2.1 ± 2.1) than in patients <40 years (1.2 ± 1.5, p < 0.001). On multivariable regression analysis, age and CHD complexity were significantly associated with the presence and number of comorbidities. CONCLUSIONS: At least one acquired comorbidity is present in approximately two-thirds of ACHD. Age and complexity of the CHD are significantly associated with the presence of comorbidities. These findings highlight the importance of addressing comorbidities in ACHD care to achieve optimal long-term outcomes.
Authors: C A Warnes; R Liberthson; G K Danielson; A Dore; L Harris; J I Hoffman; J Somerville; R G Williams; G D Webb Journal: J Am Coll Cardiol Date: 2001-04 Impact factor: 24.094
Authors: Konstantinos Dimopoulos; Gerhard-Paul Diller; Evdokia Koltsida; Antonia Pijuan-Domenech; Sofia A Papadopoulou; Sonya V Babu-Narayan; Tushar V Salukhe; Massimo F Piepoli; Philip A Poole-Wilson; Nicky Best; Darrel P Francis; Michael A Gatzoulis Journal: Circulation Date: 2008-04-28 Impact factor: 29.690
Authors: Paul C Helm; Marc-André Koerten; Hashim Abdul-Khaliq; Helmut Baumgartner; Deniz Kececioglu; Ulrike M M Bauer Journal: Cardiol Young Date: 2015-10-07 Impact factor: 1.093
Authors: Anushree Agarwal; Robert Thombley; Craig S Broberg; Ian S Harris; Elyse Foster; Vaikom S Mahadevan; Anitha John; Eric Vittinghoff; Greg M Marcus; R Adams Dudley Journal: J Am Heart Assoc Date: 2019-10-02 Impact factor: 5.501
Authors: Matthew E Oster; Aspen P Riser; Jennifer G Andrews; Elijah H Bolin; Maureen K Galindo; Wendy N Nembhard; Charles E Rose; Sherry L Farr Journal: MMWR Morb Mortal Wkly Rep Date: 2021-02-12 Impact factor: 17.586